NUWE NUWELLIS INC.....GIOIELLINO?

mastrodaniel

Nuovo Utente
Registrato
21/9/05
Messaggi
6.011
Punti reazioni
246
Dentro a 0.57 settore biotech cash 19 milioni market cap 6 ..book value 2.06......
 
Grazie mastro, seguo e entro con un chippino
 
seguo anch'io, grazie Mastro per aver condiviso il tuo trading
 
Al momento non entro. Risultati finanziari prossimo 9 agosto con conferenza ore 15:00
 
Nuwellis Announces the Submission of the AVOID-HF Clinical Analysis as a Late Breaking Clinical Trial at HFSA
Nuwellis, Inc.
Tue, July 26, 2022, 1:00 PM·5 min read
 
La pross settimana i dati.. mi aspetto il cash a14-15 milioni revenue in aumento sopra i 2.2 milioni...titolo altamente sottovalutato...ricordo che ha un book value di 2.06 dollari e cap di solo 5.8 milioni....vedremo
 
La pross settimana i dati.. mi aspetto il cash a14-15 milioni revenue in aumento sopra i 2.2 milioni...titolo altamente sottovalutato...ricordo che ha un book value di 2.06 dollari e cap di solo 5.8 milioni....vedremo

bene .. sempre dentro speriamo!
 
Out a 0,68
+18% non ci sputo..
Tanto poi farà mega spike
 
Trimestrale buona revenue in aumento loss in diminuzione e soprattutto 15.3 milioni in cash
 
Trimestrale buona revenue in aumento loss in diminuzione e soprattutto 15.3 milioni in cash

Nuwellis Inc reported a quarterly adjusted loss of 41 cents​​ per share for the quarter ended in June. The mean expectation of three analysts for the quarter was for a loss of 43 cents per share.

* Revenue fell 11.8% to $2.21 million from a year ago; analysts expected $2.12 million.

* Nuwellis Inc's reported EPS for the quarter was a loss of 41 cents​.

* The mean earnings estimate of analysts had fallen by about 4.1% in the last three months.​
* In the last 30 days there have been no earnings estimate revisions by analysts covering the company.

* Nuwellis Inc shares had risen by 20.9% this quarter and lost 37.6% so far this year.

* The company reported a quarterly loss of $4.29 million.

* Wall Street's median 12-month price target for Nuwellis Inc is $5.50
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
 
Trimestrale buona e fa - 5% 🤔

Anche se oggi tutto rosso
 
l'hanno presa male...

0,62$
-12,9%...
 
Second-quarter research and development expenses were $1.1 million dollars, compared to $1.2 million dollars in the second quarter of 2021, while we continue to advance new product development initiatives.

The net loss for the second quarter of 2022 was $4.3 million, compared to a net loss of $4.7 million in the prior-year period.

Cash and cash equivalents were approximately $15.3 million as of June 30, 2022...:cool:
 
MINNEAPOLIS, Aug. 19, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) today announced the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually. Members of management are scheduled to present on Wednesday, August 31, 2022 at 10:00 am ET.
È il titolo scende
 
MINNEAPOLIS, Aug. 19, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) today announced the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually. Members of management are scheduled to present on Wednesday, August 31, 2022 at 10:00 am ET.
È il titolo scende

una news senza peso specifico.
si scende perchè il mercato in generale è molto debole.
 
Indietro